!-- Google Tag Manager -->

Clinical trial recruitment is not operational, it’s strategic. Let’s stop pretending otherwise.

16 March 2026

There is a quiet fiction at the heart of many clinical trials. It goes something like this: “once the protocol is finalized and sites are activated, patients will appear”. Recruitment is something we will manage later. If it slips, we will fix it with more sites, more spend, or more time. This fiction is expensive. And the data have been calling it out for years.

A large proportion of clinical trials fail to recruit as planned. As many as 80–90% miss their original recruitment milestones and timelines. Around half of trials fail to reach their initial target sample size. Poor recruitment remains one of the leading causes of trial delay and termination globally, with all the implications this brings for approvals, reimbursement, and patient outcomes. These are not rare disasters. They are routine outcomes of a system that still treats recruitment as a downstream operational problem rather than a strategic one.

And when trials fall behind, what happens next? Rescue.

Industry analyses suggest a significant proportion of studies require some form of recruitment intervention mid-study, whether that means adding new sites, opening additional countries, amending eligibility criteria, or deploying targeted engagement campaigns. Rescue strategies are so common that they have almost become part of the expected lifecycle of a trial. The uncomfortable reality is that many trials are designed with optimism and executed with correction.

What makes this particularly frustrating is that most recruitment failures are predictable.

We know when eligibility criteria are too restrictive. We know when disease prevalence is overestimated. We know when sites are already stretched across multiple competing studies. We know when visit schedules are unrealistic for real patients with real lives. And yet, time and again, these risks are acknowledged and then politely ignored in the rush to finalize a protocol.

When recruitment falls behind, the industry response is depressingly familiar. Add sites. Open new countries. Amend the protocol. Extend timelines. Increase budgets. None of these are signs of innovation. They are symptoms of a trial that was never recruitable as designed. The uncomfortable truth is this: recruitment success is largely determined before the first patient is ever screened.

Trials that recruit well don’t simply get lucky. They plan differently. They interrogate assumptions early. They involve recruitment expertise during protocol design, not after first patient in. They ask difficult questions about patient availability, site capacity, competitive landscape, and willingness to participate, and they adjust the design accordingly. This is not about making trials easy. It is about making them realistic.

Every inclusion criterion has a recruitment cost. Every additional visit has a participation cost. Every delay has a financial and credibility cost. When those costs are ignored upfront, they show up later as missed milestones, frustrated sites, exhausted teams, rescue budgets, and underpowered studies.

If we want fewer rescue scenarios and more predictable delivery, recruitment planning has to move upstream. It belongs at the same table as statistics, safety, and regulatory strategy. Because a beautifully designed trial that cannot recruit is not a success waiting to happen. It is a failure on a delayed timeline and a second failure on patient care.

That is exactly the gap Inizio Site iMPACT is built to address. By bringing data-driven site intelligence, real-time trial insights, mock trials, and proactive site engagement into early trial planning, Inizio Site iMPACT helps sponsors design studies that sites can deliver and patients can access, reducing recruitment risk before it becomes a rescue scenario, and supporting performance throughout the life of the trial.

Stop Rescuing. Start Designing.

Join our live webinar on 30 April at 8.00 PDT / 11.00 EDT / 16.00 BST to learn how to build recruitability into trial design from day one – and reduce costly rescue scenarios: Register here